Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Common Equity (2021 - 2023)

Historic Common Equity for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $424.3 million.

  • Zymeworks' Common Equity rose 13606.4% to $424.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $424.3 million, marking a year-over-year increase of 13606.4%. This contributed to the annual value of $493.0 million for FY2022, which is 9789.96% up from last year.
  • Per Zymeworks' latest filing, its Common Equity stood at $424.3 million for Q3 2023, which was up 13606.4% from $448.9 million recorded in Q2 2023.
  • Zymeworks' 5-year Common Equity high stood at $493.0 million for Q4 2022, and its period low was $179.8 million during Q3 2022.
  • Over the past 3 years, Zymeworks' median Common Equity value was $436.6 million (recorded in 2023), while the average stood at $378.1 million.
  • In the last 5 years, Zymeworks' Common Equity soared by 9789.96% in 2022 and then surged by 13606.4% in 2023.
  • Zymeworks' Common Equity (Quarter) stood at $249.1 million in 2021, then skyrocketed by 97.9% to $493.0 million in 2022, then decreased by 13.92% to $424.3 million in 2023.
  • Its Common Equity stands at $424.3 million for Q3 2023, versus $448.9 million for Q2 2023 and $473.5 million for Q1 2023.